Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma.
Wierenga APA, Cao J, Luyten GPM, Jager MJ. Wierenga APA, et al. Among authors: jager mj. Int Ophthalmol Clin. 2019 Spring;59(2):53-63. doi: 10.1097/IIO.0000000000000263. Int Ophthalmol Clin. 2019. PMID: 30908279 Review. No abstract available.
Anti-angiogenic therapy in uveal melanoma.
El Filali M, Van der Velden PA, Luyten GPM, Jager MJ. El Filali M, et al. Among authors: jager mj. Dev Ophthalmol. 2012;49:117-136. doi: 10.1159/000329591. Epub 2011 Oct 21. Dev Ophthalmol. 2012. PMID: 22042017 Review.
A comparison of HLA genotype with inflammation in uveal melanoma.
van Essen TH, Bronkhorst IH, Maat W, Verduyn W, Roelen DL, Luyten GP, Jager MJ. van Essen TH, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2640-6. doi: 10.1167/iovs.11-8901. Invest Ophthalmol Vis Sci. 2012. PMID: 22447860
Analysis of inflammatory cells in uveal melanoma after prior irradiation.
Vu TH, Bronkhorst IH, Versluis M, Marinkovic M, van Duinen SG, Vrolijk J, Luyten GP, Jager MJ. Vu TH, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2013 Jan 14;54(1):360-9. doi: 10.1167/iovs.12-9424. Invest Ophthalmol Vis Sci. 2013. PMID: 23211827
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G, Luk SJ, Cao J, Dogrusöz M, van der Steen DM, Hagedoorn RS, Krijgsman D, van der Velden PA, Field MG, Luyten GPM, Szuhai K, Harbour JW, Jordanova ES, Heemskerk MHM, Jager MJ. Gezgin G, et al. Among authors: jager mj. JAMA Ophthalmol. 2017 Jun 1;135(6):541-549. doi: 10.1001/jamaophthalmol.2017.0729. JAMA Ophthalmol. 2017. PMID: 28448663 Free PMC article.
Treatment of conjunctival melanoma in a Dutch referral centre.
Brouwer NJ, Marinkovic M, van Duinen SG, Bleeker JC, Jager MJ, Luyten GPM. Brouwer NJ, et al. Among authors: jager mj. Br J Ophthalmol. 2018 Sep;102(9):1277-1282. doi: 10.1136/bjophthalmol-2017-311082. Epub 2017 Nov 9. Br J Ophthalmol. 2018. PMID: 29122819
Pigmentation of conjunctival melanoma recurrences and outcome.
Brouwer NJ, Marinkovic M, Luyten GPM, Shields CL, Jager MJ. Brouwer NJ, et al. Among authors: jager mj. Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1783-1788. doi: 10.1007/s00417-019-04342-x. Epub 2019 May 16. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31098751
Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma.
Wierenga APA, Cao J, Mouthaan H, van Weeghel C, Verdijk RM, van Duinen SG, Kroes WGM, Dogrusöz M, Marinkovic M, van der Burg SSH, Luyten GPM, Jager MJ. Wierenga APA, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4740-4747. doi: 10.1167/iovs.19-28309. Invest Ophthalmol Vis Sci. 2019. PMID: 31731294
339 results